News Focus
News Focus
icon url

dailybagel

02/15/12 9:44 AM

#90241 RE: Mr Wizard #90239

Michael E. Herman was the executing official who signed TA-1 form on 07/05/2011 in order to register Baron Capital Transfer & Registrar, LLC as a Transfer Agent with the SEC.
icon url

Hotbit

02/15/12 9:50 AM

#90243 RE: Mr Wizard #90239

My guess is this guy.......


E-Mail | del.icio.us | Share | RSS | Print
Michael E. Herman

Independent Director
Santarus, Inc.
San Diego , CA
Sector: HEALTHCARE / Drug Manufacturers - Other

Independent Director , Senomyx, Inc.
San Diego , CA
Sector: SERVICES / Food Wholesale

69 Years Old
Michael E. Herman has served as a member of our board of directors since September 2003. From January 1992 to December 2000, Mr. Herman was President of the Kansas City Royals Baseball Club. From January 1990 to December 1999, he was Chairman of the Finance and Investment Committee of the Kauffman Foundation and was its President from January 1985 to December 1990. From October 1974 to December 1990, Mr. Herman was the Executive Vice President and Chief Financial Officer of Marion Laboratories. Mr. Herman is a director of Senomyx, Inc., a biotechnology company, Cerner Corporation, a health care information technology company, and also is a Trustee of Rensselaer Polytechnic Institute and the University of Chicago Graduate School of Business. He also serves as a member of the board of directors of Vail Valley Foundation and New Enterprise Associates. Mr. Herman also previously served as a director of Janus Capital, Eloquent, Inc. and Agouron Pharmaceuticals, Inc. Mr. Herman holds a B.S. in metallurgical engineering from Rensselaer Polytechnic Institute and an M.B.A. from the University of Chicago. In selecting Mr. Herman to serve as a director, the board considered, among other things, his valuable business and financial expertise, both within and outside the life sciences industry, including prior service with Marion Laboratories. Santarus also benefits from Mr. Herman?s current involvement in the healthcare and biotechnology industries through his director positions with Cerner Corporation and Senomyx, Inc.
Director Compensation (Santarus, Inc.) for 2009
Fees earned or paid in cash $65,000.00
Stock awards $0.00
Option awards (in $) $76,502.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $141,502.00
Director Compensation (Cerner Corporation) for 2008
Fees earned or paid in cash $73,875.00
Stock awards $143,241.00
Option awards (in $) $0.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $217,116.00
Director Compensation (Cerner Corporation) for 2007
Fees earned or paid in cash $54,975.00
Stock awards $137,551.00
Option awards (in $) $0.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $192,526.00
Director Compensation (Cerner Corporation) for 2006
Fees earned or paid in cash $36,950.00
Stock awards $134,963.00
Option awards (in $) $0.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $171,913.00
Director Compensation (Cerner Corporation) for 2005
Fees earned or paid in cash $41,400.00
Stock awards $0.00
Option awards (in $) $0.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $41,400.00
Director Compensation (Santarus, Inc.) for 2008
Fees earned or paid in cash $52,000.00
Stock awards $0.00
Option awards (in $) $74,746.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $126,746.00
Director Compensation (Santarus, Inc.) for 2007
Fees earned or paid in cash $54,000.00
Stock awards $0.00
Option awards (in $) $124,496.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $178,496.00
Director Compensation (Santarus, Inc.) for 2006
Fees earned or paid in cash $65,759.00
Stock awards $0.00
Option awards (in $) $105,502.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $171,261.00
Director Compensation (Senomyx, Inc.) for 2008
Fees earned or paid in cash $35,750.00
Stock awards $0.00
Option awards (in $) $67,611.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $103,361.00
Director Compensation (Senomyx, Inc.) for 2007
Fees earned or paid in cash $50,000.00
Stock awards $0.00
Option awards (in $) $120,154.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $170,154.00
Director Compensation (Senomyx, Inc.) for 2006
Fees earned or paid in cash $66,286.00
Stock awards $0.00
Option awards (in $) $133,369.00
Non-equity incentive plan compensation $0.00
Change in pension value and nondisqualified compensation earnings $0.00
All other compensation $0.00
Total Compensation $199,655.00

RSS Feed on Michael Herman
Forbes.com Headlines
Suze Orman: 'The American Dream Is Dead'
Jenna Goudreau
Financial guru Suze Orman says the American dream is dead for most Americans.
Home Stretch
Brandon Copple
After a seven-year ownership struggle David Glass and Kansas City finally play ball.